NASDAQ:GELS

Gelteq (GELS) Stock Price, News & Analysis

Gelteq logo
$0.28 +0.01 (+3.93%)
Closing price 11/19/2026 03:59 PM Eastern
Extended Trading
$0.28 0.00 (-0.57%)
As of 11/19/2026 04:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Gelteq Stock (NASDAQ:GELS)

Advanced

Key Stats

Today's Range
$0.28
▼
$0.30
50-Day Range
$0.27
▼
$0.70
52-Week Range
$0.26
▼
$2.01
Volume
10,956 shs
Average Volume
74,865 shs
Market Capitalization
$3.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Gelteq is an Australian food-technology company that develops gel-based delivery systems for ingredients used in human and animal health products. Its platform is designed to incorporate active ingredients into gels as an alternative format to conventional tablets, capsules, powders and liquids.

The company’s applications include nutraceuticals and dietary supplements, pharmaceutical products, and animal-health and nutrition products. Gelteq works with businesses seeking to develop or manufacture products using its gel technology.

AI Generated. May Contain Errors.

Gelteq Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

GELS MarketRank™: 
0.92029185022 of 5 stars

Gelteq scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Gelteq has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Gelteq has only been the subject of 1 research reports in the past 90 days.

  • Read more about Gelteq's stock forecast and price target.
  • Price to Book Value per Share Ratio

    Gelteq has a P/B Ratio of 0.26. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.13% of the float of Gelteq has been sold short.
  • Short Interest Ratio / Days to Cover

    Gelteq has a short interest ratio ("days to cover") of 2.08, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Gelteq has recently decreased by 27.48%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Gelteq does not currently pay a dividend.

  • Dividend Growth

    Gelteq does not have a long track record of dividend growth.

  • News Sentiment

    Gelteq has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Gelteq this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Gelteq insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Gelteq has minimal institutional ownership at this time.

  • Read more about Gelteq's insider trading history.
Receive GELS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gelteq and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GELS Stock News Headlines

Gelteq Limited Reports Delay in Annual Filing
Under 3 cents a night
Bill Poulos's Black Friday deal: a full year of the Instant Scanner for $7, one payment. The regular price is $247, about a dollar a night. With roughly 250 trading nights a year, that's 2.8 cents a night to have nearly a thousand of America's biggest stocks checked, with exact buy prices on whatever qualifies. No re-bills and nothing to install. At $7, the only question is whether you get around to it.tc pixel
Could Gelteq’s (GELS) Gel Improve Oral Drug Delivery?
See More Headlines

GELS Stock Analysis - Frequently Asked Questions

Gelteq's stock was trading at $0.80 at the start of the year. Since then, GELS shares have decreased by 64.9% and is now trading at $0.2806.

Gelteq Limited (NASDAQ:GELS) posted its earnings results on Monday, November, 16th. The company reported ($0.64) earnings per share (EPS) for the quarter.

Gelteq (GELS) raised $5 million in an initial public offering (IPO) on Tuesday, October 29th 2024. The company issued 1,300,000 shares at $4.00 per share. The Benchmark Company acted as the underwriter for the IPO.

Shares of GELS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/16/2026
Today
11/19/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:GELS
Previous Symbol
NASDAQ:GELS
CIK
1920092
Fax
N/A
Employees
18
Year Founded
2018

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$240 thousand
Price / Sales
13.46
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.08 per share
Price / Book
0.26

Miscellaneous

Outstanding Shares
11,510,000
Free Float
N/A
Market Cap
$3.23 million
Optionable
N/A
Beta
-0.37

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NASDAQ:GELS) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners